Please ensure Javascript is enabled for purposes of website accessibility

Kimberly-Clark Buys Life-Tech Anesthesia Business

By Rich Smith - Apr 2, 2013 at 1:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Texas-based Life-Point unit will go to the big company that used to distribute its products.

Probably best-known for its Huggies diapers and Kleenex tissues, Kimberly-Clark (KMB 0.77%) is donning surgical scrubs and heading into the hospital this morning, with an announcement that it's just bought the anesthesia business of privately held Life-Tech.

Like Kimberly-Clark, Life-Tech is a Texas-based company. The acquired portion of the Life-Tech business manufactures needles, catheters, and accessories associated with peripheral nerve block procedures, and historically, Kimberly-Clark has acted as a distributor of the company's products. Now, Kimberly-Clark is bringing the business in-house, and incorporating it into the Kimberly-Clark Health Care division, which accounts for about 7% of Kimberly-Clark's total revenues.

"The Life-Tech assets will allow [Kimberly-Clark Health Care's] ON-Q to capitalize on its leading position in the pain pump market and enhance margins on these products through internal manufacturing," the company said.

Financial details of the acquisition are not being disclosed -- neither the cost of the Life-Tech business, nor its anticipated effect on K-C's profits or revenues. Investors sent Kimberly-Clark shares up 1.7% to about $99.63 in early trading.


Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Kimberly-Clark Corporation Stock Quote
Kimberly-Clark Corporation
$133.43 (0.77%) $1.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.